These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24344833)

  • 1. Acute kidney injury induced by aristolochic acid in patients with primary glomerular nephritis.
    Tang Z; Chen D; Zhang Y; Chen Z; Chen H; Zeng C; Liu Z
    Ren Fail; 2014 Apr; 36(3):367-71. PubMed ID: 24344833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological spectrums of aristolochic acid nephropathy.
    Chen D; Tang Z; Luo C; Chen H; Liu Z
    Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and long-term follow-up analysis of three cases with newborn aristolochic acid nephropathy].
    Li ZH; Wei M; Ding GF; Wang DH
    Zhonghua Er Ke Za Zhi; 2011 Nov; 49(11):814-7. PubMed ID: 22336301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aristolochic acid nephropathy: variation in presentation and prognosis.
    Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
    Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aristolochic acid induces renal tubular injury and inhibits expression of bone morphogenetic protein-7 mRNA in renal tissue of rats].
    Wang HL; Zhang JY
    Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):501-7. PubMed ID: 18471416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical and pathological manifestations of aristolochic acid nephropathy--the report of 58 cases].
    Chen W; Chen Y; Li A
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1101-5. PubMed ID: 11766606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets.
    Declèves AÉ; Jadot I; Colombaro V; Martin B; Voisin V; Nortier J; Caron N
    Exp Physiol; 2016 Jan; 101(1):193-206. PubMed ID: 26442795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy.
    Yi JH; Han SW; Kim WY; Kim J; Park MH
    Korean J Intern Med; 2018 Jul; 33(4):763-773. PubMed ID: 28192889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of aristolochic acid nephropathy in Korea.
    Ban TH; Min JW; Seo C; Kim DR; Lee YH; Chung BH; Jeong KH; Lee JW; Kim BS; Lee SH; Choi BS; Han JS; Yang CW
    Korean J Intern Med; 2018 Sep; 33(5):961-969. PubMed ID: 29551056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy].
    Li X; Yang L; Yu Y
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):681-7. PubMed ID: 11769723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy.
    Sun D; Feng J; Dai C; Sun L; Jin T; Ma J; Wang L
    Am J Nephrol; 2006; 26(4):363-71. PubMed ID: 16873992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin.
    Yang HY; Lin JL; Chen KH; Yu CC; Hsu PY; Lin CL
    J Nephrol; 2006; 19(1):111-4. PubMed ID: 16523436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin E1 on the progression of aristolochic acid nephropathy.
    Sun D; Feng JM; Zhao YL; Jin T; Wang LN
    Chin Med Sci J; 2005 Mar; 20(1):67-9. PubMed ID: 15844319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy.
    Shi M; Ma L; Zhou L; Fu P
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27763560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats.
    Zhao YY; Zhang L; Mao JR; Cheng XH; Lin RC; Zhang Y; Sun WJ
    J Pharm Pharmacol; 2011 Dec; 63(12):1581-6. PubMed ID: 22060289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of mitochondrial injury in Caulis Aristolochia manshuriensis-induced chronic aristolochic acid nephropathy.
    Liu X; Wu J; Wang J; Fan J; Feng X; Yu X; Yang X
    Drug Chem Toxicol; 2017 Jan; 40(1):115-124. PubMed ID: 27250112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.
    Jadot I; Declèves AE; Nortier J; Caron N
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?
    Pozdzik AA; Berton A; Schmeiser HH; Missoum W; Decaestecker C; Salmon IJ; Vanherweghem JL; Nortier JL
    Histopathology; 2010 Mar; 56(4):449-63. PubMed ID: 20459552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case of traditional herbal medicine-induced aristolochic acid nephropathy developing to end-stage renal failure].
    Fujimura T; Tamaki K; Iida S; Tanaka H; Ikedou H; Takamiya Y; Kato S; Tanaka A; Okuda S
    Nihon Jinzo Gakkai Shi; 2005; 47(4):474-80. PubMed ID: 15971892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.